Document is current

Any future updates will be listed below

FL: Relevante klinische Vorteile durch Axicabtagen-Ciloleucel

Crossref DOI link: https://doi.org/10.1007/s15004-021-8742-3

Published Online: 2021-07-28

Published Print: 2021-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark